HFA
GILD icon

High Falls Advisors’s Gilead Sciences GILD Stock Holding History

High Falls Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-18,055
Closed -$1.83M – 92
2016
Q2 		$1.83M Buy
18,055
+6,542
+57% +$581K 0.52% 26
2016
Q1 		$1.06M Sell
11,513
-6,542
-36% -$590K 0.37% 33
2015
Q4 		$1.83M Buy
+18,055
New +$1.88M 0.52% 26

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

High Falls Advisors's GILD Position: Q3 2016 in Review

High Falls Advisors sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 18,055 shares — an estimated $1.83M sold.

High Falls Advisors first reported a position in GILD in Q4 2015 and held it in 3 quarters. The position peaked at $1.83M in Q2 2016. 1,558 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • High Falls Advisors reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
  • High Falls Advisors sold 18,055 Gilead Sciences shares in Q3 2016, an estimated $1.83M.
  • High Falls Advisors first reported a position in Gilead Sciences in Q4 2015 and held it in 3 quarters.
  • High Falls Advisors's Gilead Sciences position peaked at $1.83M in Q2 2016.
  • 1,558 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on High Falls Advisors's 13F filing for Q3 2016, filed 16 Nov 2016.